Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
98,364,308
-
Total 13F shares
-
5,053,799
-
Share change
-
+5,053,799
-
Total reported value
-
$50,841,000
-
Price per share
-
$10.05
-
Number of holders
-
21
-
Value change
-
+$50,841,000
-
Number of buys
-
21
Institutional Holders of Oncology Institute, Inc. - Common (DFPH) as of Q2 2020
As of 30 Jun 2020,
Oncology Institute, Inc. - Common (DFPH) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,053,799 shares.
The largest 10 holders included
UBS OCONNOR LLC, DEUTSCHE BANK AG\, HBK INVESTMENTS L P, Radcliffe Capital Management, L.P., FIR TREE CAPITAL MANAGEMENT LP, MOORE CAPITAL MANAGEMENT, LP, Hudson Bay Capital Management LP, PICTON MAHONEY ASSET MANAGEMENT, Owl Creek Asset Management, L.P., and Jefferies Group LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.